Biomarkers to guide medical therapy in primary aldosteronism

GL Hundemer, AA Leung, GA Kline… - Endocrine …, 2024 - academic.oup.com
Primary aldosteronism (PA) is an endocrinopathy characterized by dysregulated
aldosterone production that occurs despite suppression of renin and angiotensin II, and that …

Management of Resistant Hypertension

L Lauder, F Mahfoud, M Böhm - Annual Review of Medicine, 2024 - annualreviews.org
Resistant hypertension (RH) is a severe form of hypertension associated with increased
cardiovascular risk. Although true RH affects less than 10% of the patients receiving …

Subclinical primary aldosteronism and cardiovascular health: a population-based cohort study

GL Hundemer, M Agharazii, F Madore, A Vaidya… - Circulation, 2024 - Am Heart Assoc
BACKGROUND: Primary aldosteronism, characterized by overt renin-independent
aldosterone production, is a common but underrecognized form of hypertension and …

[PDF][PDF] Comprehensive Management of Hypertension: Strategies, Guidelines, and Emerging Therapies

I Karunarathna, K Kusumarathna… - Uva Clinical Lab …, 2024 - researchgate.net
Hypertension, a leading risk factor for cardiovascular disease, poses a significant public
health challenge globally. This article explores the multifaceted approach to hypertension …

Mineralocorticoid receptor overactivation: targeting systemic impact with non-steroidal mineralocorticoid receptor antagonists

G Savarese, F Lindberg, G Filippatos, J Butler… - Diabetologia, 2024 - Springer
The overactivation of the mineralocorticoid receptor (MR) promotes pathophysiological
processes related to multiple physiological systems, including the heart, vasculature …

Aldosterone and aldosterone synthase inhibitors in cardiorenal disease

S Verma, A Pandey, AK Pandey… - American Journal …, 2024 - journals.physiology.org
Modulation of the renin-angiotensin-aldosterone system is a foundation of therapy for
cardiovascular and kidney diseases. Excess aldosterone plays an important role in …

Evaluation of a best-practice advisory for primary aldosteronism screening

S Charoensri, L Bashaw, C Dehmlow… - JAMA Internal …, 2024 - jamanetwork.com
Importance Primary aldosteronism (PA) is a common cause of secondary hypertension and
an independent risk factor for cardiovascular morbidity and mortality. Fewer than 2% to 4 …

The spectrum of dysregulated aldosterone production: An international human physiology study

WW Parksook, JM Brown, K Omata… - The Journal of …, 2024 - academic.oup.com
Context Primary aldosteronism is a form of low-renin hypertension characterized by
dysregulated aldosterone production. Objective To investigate the contributions of renin …

Efficacy and safety of mineralocorticoid receptor antagonists for the treatment of low-renin hypertension: a systematic review and meta-analysis

SS Shah, J Zhang, SM Gwini, MJ Young… - Journal of Human …, 2024 - nature.com
Hypertension is the leading risk factor for premature death. The optimal treatment of low-
renin hypertension (LRH), present in 30% of hypertensive individuals, is not known. LRH …

10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2024

Diabetes Care, 2024 - Am Diabetes Assoc
The American Diabetes Association (ADA)“Standards of Care in Diabetes” includes the
ADA's current clinical practice recommendations and is intended to provide the components …